The OECD.AI Policy Navigator

Our policy navigator is a living repository from more than 80 jurisdictions and organisations. Use the filters to browse initiatives and find what you are looking for.

AI in Protontherapy


Added by:   National contact point
Added on:   06 Oct 2025
Updated by:   OECD analyst
Updated on:   25 Dec 2025

A collaboration between Maastricht UMC+, UMCG and Raysearch have developed an AI proton therapy treatment plan, where the AI developed the plan rather than a radiotherapy planning technician. This treatment is specifically for patients with health and neck cancer. The new technology is able to develop the treatment plan within 2.5 hours with clinical review, rather than two days.

Name in original language

-

Initiative overview

The AI-driven proton therapy planning project, developed through collaboration between University Medical Center Groningen (UMCG) and RaySearch, aims to automate the creation of robust treatment plans for head and neck cancer patients. The system uses a machine learning model trained on historical data from 80 patients to infer dose distributions and generate intensity-modulated proton therapy (IMPT) plans. The primary goals of the project are to reduce manual workload, improve planning efficiency, and maintain clinical quality and robustness. The framework supports rapid plan generation—under 20 minutes—and is designed to facilitate adaptive therapy and modality comparisons between photon and proton treatments. 

Name of responsible organisation (in English)

Maastricht UMC+, UMCG and Raysearch

About the policy initiative


Organisation:

  • Maastricht UMC+, UMCG and Raysearch

Category:

  • AI policy initiatives, programmes and projects

Initiative type:

  • AI Research Centres/Centres of Excellence/Expertise, specialised AI teams, labs

Status:

  • Active

Start Year:

  • 2024

Binding:

  • Non-binding

Other relevant urls: